Enveric Biosciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENVB and other ETFs, options, and stocks.

About ENVB

Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments.

CEO

Joseph Tucker

CEOJoseph Tucker

Employees

Employees5

Headquarters

Naples, Florida

HeadquartersNaples, Florida

Founded

1994

Founded1994

Employees

Employees5

ENVB Key Statistics

Market cap

3.67M

Market cap3.67M

Price-Earnings ratio

-0.11

Price-Earnings ratio-0.11

Dividend yield

—

Dividend yield—

Average volume

530.44K

Average volume530.44K

High today

$1.29

High today$1.29

Low today

$1.11

Low today$1.11

Open price

$1.25

Open price$1.25

Volume

488.24K

Volume488.24K

52 Week high

$8.40

52 Week high$8.40

52 Week low

$1.01

52 Week low$1.01

ENVB News

TipRanks 3d

Enveric Biosciences Releases New Investor Presentation

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 4d

Enveric Biosciences completes EB-003 dose range finding toxicology studies

Enveric Biosciences (ENVB) announced the successful completion of seven-day dose range finding toxicology studies in two preclinical species for its lead drug c...

People also own

Based on the portfolios of people who own ENVB. This list is generated using Robinhood data, and it’s not a recommendation.